Drug Developer Applies For FDA Emergency Authorization For Anti-COVID Pill Molnupiravir

The New York Times (10/11, Robbins) reports Merck & Co. has submitted an application to the FDA “to authorize what would be the first antiviral pill to treat COVID-19” and “a milestone in the fight against the coronavirus.” The therapy, “taken at home as...